Prophylactic cranial irradiation beneficial in elderly SCLC patients
Prophylactic cranial irradiation improves survival in elderly patients with limited-stage small-cell lung cancer, analysis of US epidemiologic data indicates. (Source: MedWire News - Oncology)
Source: MedWire News - Oncology - September 6, 2013 Category: Cancer & Oncology Source Type: news
Prophylactic cranial irradiation beneficial in elderly SCLC patients
Prophylactic cranial irradiation improves survival in elderly patients with limited-stage small-cell lung cancer, analysis of US epidemiologic data indicates. (Source: MedWire News - Respiratory)
Source: MedWire News - Respiratory - September 6, 2013 Category: Respiratory Medicine Source Type: news
Chemotherapy helps elderly patients with small cell lung cancer
(International Association for the Study of Lung Cancer) In the Oct. issue of the International Association for the Study of Lung Cancer's journal, the Journal of Thoracic Oncology, researchers conclude that chemotherapy is associated with a greater than six-month improvement in median survival among elderly patients with SCLC, even in patients over the age of 80 years. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - September 4, 2013 Category: Global & Universal Source Type: news
Roche launches new ProGRP test for more precise diagnosis in lung cancer
New test expands cancer diagnostics portfolio and strengthens Roche Diagnostics’ comprehensive tumour marker menu. Roche today announced the global launch (except US) of Elecsys ProGRP, a test that distinguishes between the two main types of lung cancer – small cell (SCLC) and non-small cell (NSCLC) lung cancer – and can help diagnose early-stage SCLC. (Source: Roche Media News)
Source: Roche Media News - July 18, 2013 Category: Pharmaceuticals Source Type: news
Care Of Limited-Stage Small-Cell Lung Cancer Patients Improved By PET-CT
Each year, 13 percent of all newly diagnosed lung cancer patients are diagnosed with small-cell lung cancer (SCLC). Approximately 39 percent of patients with SCLC are diagnosed with limited-stage disease, meaning the cancer is only present in one lung, but may have spread to lymph nodes or tissue between the lungs. These patients are often treated with chemotherapy and definitive radiation therapy... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - June 28, 2013 Category: Consumer Health News Tags: Lung Cancer Source Type: news
Silenced miR points to poor SCLC prognosis
Chinese scientists have identified a molecular marker that significantly predicts the survival of patients with small-cell lung cancer. (Source: MedWire News - Lung Cancer)
Source: MedWire News - Lung Cancer - June 7, 2013 Category: Cancer & Oncology Source Type: news
Silenced miR points to poor SCLC prognosis
Chinese scientists have identified a molecular marker that significantly predicts the survival of patients with small-cell lung cancer. (Source: MedWire News - Oncology)
Source: MedWire News - Oncology - June 7, 2013 Category: Cancer & Oncology Source Type: news
Silenced miR points to poor SCLC prognosis
Chinese scientists have identified a molecular marker that significantly predicts the survival of patients with small-cell lung cancer. (Source: MedWire News - Respiratory)
Source: MedWire News - Respiratory - June 7, 2013 Category: Respiratory Medicine Source Type: news
Ipilimumab in Combination With Paclitaxel and Carboplatin in SCLCIpilimumab in Combination With Paclitaxel and Carboplatin in SCLC
This study enrolled patients with ED-SCLC as well as those with advanced NSCLC. Results for the ED-SCLC cohort are presented here. Annals of Oncology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - February 11, 2013 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news
Cerulean doses first patient in Phase 2 study of small cell lung cancer drug
US based clinical-stage company Cerulean Pharma has dosed the first patient in a randomised Phase 2 study of its anti-cancer drug for treating extensive-stage small cell lung cancer (SCLC). (Source: Drug Development Technology)
Source: Drug Development Technology - February 4, 2013 Category: Pharmaceuticals Source Type: news
